Literature DB >> 17646599

Reducing the population burden of cardiovascular disease by reducing sodium intake: a report of the Council on Science and Public Health.

Barry D Dickinson1, Stephen Havas.   

Abstract

Across populations, the level of blood pressure, the incremental rise in blood pressure with age, and the prevalence of hypertension are directly related to sodium intake. Observational studies and randomized controlled trials document a consistent effect of sodium consumption on blood pressure. The majority of sodium consumption in the United States is derived from amounts added during food processing and preparation. Leading scientific organizations and governmental agencies advise limiting sodium intake to 2400 mg or less daily (approximately 6000 mg of salt). Substantial public health benefits accrue from small reductions in the population blood pressure distribution. A 1.3-g/d lower lifetime sodium intake translates into an approximately 5-mm Hg smaller rise in systolic blood pressure as individuals advance from 25 to 55 years of age, a reduction estimated to save 150,000 lives annually. With an appropriate food industry response, combined with consumer education and knowledgeable use of food labels, the average consumer should be able to choose a lower-sodium diet without inconvenience or loss of food enjoyment. In the continued absence of voluntary measures adopted by the food industry, new regulations will be required to achieve lower sodium concentrations in processed and prepared foods.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17646599     DOI: 10.1001/archinte.167.14.1460

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  25 in total

Review 1.  Salt restriction for the prevention of cardiovascular disease.

Authors:  Dieter Klaus; Joachim Hoyer; Martin Middeke
Journal:  Dtsch Arztebl Int       Date:  2010-07-02       Impact factor: 5.594

2.  Vitamin D3 therapy corrects the tissue sensitivity to angiotensin ii akin to the action of a converting enzyme inhibitor in obese hypertensives: an interventional study.

Authors:  Anand Vaidya; Bei Sun; Carol Larson; John P Forman; Jonathan S Williams
Journal:  J Clin Endocrinol Metab       Date:  2012-04-26       Impact factor: 5.958

3.  To reduce urban disparities in health, strengthen and enforce equitably environmental and consumer laws.

Authors:  Kenneth Olden; Rose Marie Ramos; Nicholas Freudenberg
Journal:  J Urban Health       Date:  2009-11       Impact factor: 3.671

Review 4.  The cost-effectiveness of interventions designed to reduce sodium intake.

Authors:  Guijing Wang; Darwin Labarthe
Journal:  J Hypertens       Date:  2011-09       Impact factor: 4.844

5.  Dietary Sodium and Cardiovascular Disease Risk--Measurement Matters.

Authors:  Mary E Cogswell; Kristy Mugavero; Barbara A Bowman; Thomas R Frieden
Journal:  N Engl J Med       Date:  2016-06-01       Impact factor: 91.245

6.  Vitamin D and the vascular sensitivity to angiotensin II in obese Caucasians with hypertension.

Authors:  A Vaidya; J P Forman; J S Williams
Journal:  J Hum Hypertens       Date:  2010-12-02       Impact factor: 3.012

7.  Effectiveness and Feasibility of Taxing Salt and Foods High in Sodium: A Systematic Review of the Evidence.

Authors:  Rebecca Dodd; Joseph Alvin Santos; Monique Tan; Norm R C Campbell; Cliona Ni Mhurchu; Laura Cobb; Michael F Jacobson; Feng J He; Kathy Trieu; Sutayut Osornprasop; Jacqui Webster
Journal:  Adv Nutr       Date:  2020-11-16       Impact factor: 8.701

8.  Dietary approaches to prevent hypertension.

Authors:  Lydia A Bazzano; Torrance Green; Teresa N Harrison; Kristi Reynolds
Journal:  Curr Hypertens Rep       Date:  2013-12       Impact factor: 5.369

9.  Interindividual variation in serum sodium and longitudinal blood pressure tracking in the Framingham Heart Study.

Authors:  Rodrigo M Lago; Michael J Pencina; Thomas J Wang; Katherine J Lanier; Ralph B D'Agostino; William B Kannel; Ramachandran S Vasan
Journal:  J Hypertens       Date:  2008-11       Impact factor: 4.844

10.  Sociology meets genetics: sociogenetic implications for future management of hypertension and heart failure.

Authors:  Randy Wexler; Adam Pleister; David Feldman
Journal:  Curr Treat Options Cardiovasc Med       Date:  2009-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.